Capital Wealth Planning LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1,847.5% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 150,733 shares of the healthcare conglomerate’s stock after acquiring an additional 142,993 shares during the quarter. UnitedHealth Group makes up approximately 4.5% of Capital Wealth Planning LLC’s holdings, making the stock its 3rd biggest holding. Capital Wealth Planning LLC’s holdings in UnitedHealth Group were worth $27,949,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of UNH. Harbour Capital Advisors LLC increased its position in shares of UnitedHealth Group by 18,383.4% during the second quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock worth $13,573,000 after acquiring an additional 2,503,090 shares during the period. Jennison Associates LLC increased its position in shares of UnitedHealth Group by 180.4% during the second quarter. Jennison Associates LLC now owns 2,252,507 shares of the healthcare conglomerate’s stock worth $417,660,000 after acquiring an additional 1,449,130 shares during the period. State Street Corp increased its position in shares of UnitedHealth Group by 2.5% during the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock worth $7,499,276,000 after acquiring an additional 1,122,534 shares during the period. American Century Companies Inc. increased its position in shares of UnitedHealth Group by 16.9% during the second quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock worth $872,051,000 after acquiring an additional 681,111 shares during the period. Finally, William Blair Investment Management LLC increased its position in shares of UnitedHealth Group by 88.9% during the first quarter. William Blair Investment Management LLC now owns 1,317,807 shares of the healthcare conglomerate’s stock worth $216,134,000 after acquiring an additional 620,113 shares during the period. 86.00% of the stock is currently owned by institutional investors and hedge funds.

UNH has been the topic of several research reports. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, October 10th. ValuEngine lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Cantor Fitzgerald reissued a “buy” rating and set a $208.00 price objective on shares of UnitedHealth Group in a report on Tuesday, October 17th. Piper Jaffray Companies lifted their price objective on shares of UnitedHealth Group to $228.00 and gave the company an “overweight” rating in a report on Tuesday, October 17th. Finally, Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $210.00 to $215.00 and gave the company an “overweight” rating in a report on Thursday, August 17th. Three equities research analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $216.65.

In related news, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the completion of the transaction, the director now owns 60,834 shares of the company’s stock, valued at $12,135,774.66. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction on Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the transaction, the director now directly owns 1,818,898 shares of the company’s stock, valued at approximately $348,700,935.58. The disclosure for this sale can be found here. In the last three months, insiders have sold 72,606 shares of company stock valued at $14,308,783. 0.89% of the stock is currently owned by corporate insiders.

UnitedHealth Group Incorporated (NYSE:UNH) opened at $209.90 on Friday. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52. UnitedHealth Group Incorporated has a fifty-two week low of $148.56 and a fifty-two week high of $213.93. The stock has a market cap of $204,130.00, a price-to-earnings ratio of 22.05, a P/E/G ratio of 1.57 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. During the same quarter last year, the company posted $2.17 earnings per share. The firm’s revenue was up 8.7% compared to the same quarter last year. analysts forecast that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be issued a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $3.00 annualized dividend and a dividend yield of 1.43%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.09%.

TRADEMARK VIOLATION WARNING: This piece was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/11/19/capital-wealth-planning-llc-buys-142993-shares-of-unitedhealth-group-incorporated-unh.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.